Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Recruiting Observational Study
Breast Cancers Ovarian Cancers
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Institut Paoli-Calmettes · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1. Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over. 1. Woman with or without breast cancer or ovarian cancer at baseline. 2. Man with or without breast cancer at baseline. 2. Signed consent to participation 3. Affiliation to a social s…
Contacts

Dominique GENRE, MD

33 491 22 37 78

DRCI.UP@ipc.unicancer.fr

CONTACT

Margot BERLINE, MSc, MBA

33 491 22 33 14

DRCI.UP@ipc.unicancer.fr

CONTACT